IN2012DN01414A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01414A
IN2012DN01414A IN1414DEN2012A IN2012DN01414A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A IN 1414DEN2012 A IN1414DEN2012 A IN 1414DEN2012A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A
Authority
IN
India
Prior art keywords
nitroimidazooxazines
drugs
alone
novel
preparation
Prior art date
Application number
Inventor
William Alexander Denny
Andrew M Thompson
Adrian Blaser
Zhenkun Ma
Brian Desmond Palmer
Hamish Scott Sutherland
Iveta Kmentova
Original Assignee
Global Alliance For Tb Drug Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Alliance For Tb Drug Dev filed Critical Global Alliance For Tb Drug Dev
Publication of IN2012DN01414A publication Critical patent/IN2012DN01414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention relates to novel nitroimidazooxazines, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
IN1414DEN2012 2009-07-31 2010-07-30 IN2012DN01414A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23039609P 2009-07-31 2009-07-31
PCT/US2010/043906 WO2011014774A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazines and their uses in anti-tubercular therapy

Publications (1)

Publication Number Publication Date
IN2012DN01414A true IN2012DN01414A (en) 2015-06-05

Family

ID=42937154

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1414DEN2012 IN2012DN01414A (en) 2009-07-31 2010-07-30

Country Status (12)

Country Link
EP (1) EP2459571B1 (en)
JP (1) JP5781072B2 (en)
KR (1) KR101746482B1 (en)
CN (1) CN102753558B (en)
AU (1) AU2010278777B2 (en)
BR (1) BR112012002278A2 (en)
CA (1) CA2769359C (en)
ES (1) ES2536997T3 (en)
IN (1) IN2012DN01414A (en)
NZ (1) NZ598121A (en)
RU (1) RU2542988C2 (en)
WO (1) WO2011014774A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103596960B (en) * 2011-04-15 2016-11-16 大塚制药株式会社 6,7-Dihydroimidazo[2,1-B][1,3]oxazine fungicide
CN104059082B (en) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 Nitroimidazole heterocycle compound and the application in preparation treatment tubercular drugs thereof
KR101682356B1 (en) 2014-11-04 2016-12-06 한국화학연구원 Imidazo oxazine derivatives, pharmaceutically acceptable salts thereof or optical isomer thereof and pharmaceutical composition containing the same as an active ingredient
TW201632533A (en) 2015-01-29 2016-09-16 南京明德新藥研發股份有限公司 The nitroimidazole derivative for anti- tuberculosis uberculosis
CN108047248A (en) * 2018-02-12 2018-05-18 丹诺医药(苏州）有限公司 The application of oxazolidone-nitro glyoxaline coupling molecule
CN113527331B (en) * 2020-04-17 2024-05-28 南京长澳医药科技有限公司 Nitroimidazole derivative and preparation method and application thereof
CN113355439A (en) * 2021-06-07 2021-09-07 深圳市普瑞康生物技术有限公司 Novel combined detection method for latent infection and morbidity of mycobacterium tuberculosis
CN114469946B (en) * 2022-02-24 2023-10-24 首都医科大学附属北京胸科医院 Use of delamanib as CXCL10 inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52318A1 (en) 1994-03-08 1998-09-28 American Home Prod Novel anti-hyperglycemic agents
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
ZA200602184B (en) * 2003-10-31 2007-10-31 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis
DE602005004040T2 (en) 2004-01-16 2008-12-11 Sumitomo Chemical Co., Ltd. Malononitrile compounds as pesticides
TWI300409B (en) * 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
WO2006043121A1 (en) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
AU2006276096A1 (en) * 2005-07-28 2007-02-08 Vertex Pharmaceuticals Incorporated Caspase inhibitor prodrugs
US20080275035A1 (en) * 2005-12-23 2008-11-06 Jan Jiricek Nitroimidazole Compounds
AU2009228293B2 (en) * 2008-03-26 2012-11-08 Tennor Therapeutics (Suzhou) Limited Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Also Published As

Publication number Publication date
JP5781072B2 (en) 2015-09-16
EP2459571B1 (en) 2015-03-11
CN102753558B (en) 2014-10-15
CA2769359C (en) 2017-03-07
KR101746482B1 (en) 2017-06-27
EP2459571A1 (en) 2012-06-06
JP2013500996A (en) 2013-01-10
AU2010278777B2 (en) 2015-05-07
KR20120084713A (en) 2012-07-30
CN102753558A (en) 2012-10-24
CA2769359A1 (en) 2011-02-03
RU2012107176A (en) 2013-09-10
ES2536997T3 (en) 2015-06-01
BR112012002278A2 (en) 2020-09-15
WO2011014774A1 (en) 2011-02-03
NZ598121A (en) 2013-04-26
RU2542988C2 (en) 2015-02-27
AU2010278777A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
PH12012501841B1 (en) Anti-infective compounds
IN2012DN01414A (en)
MX2019009132A (en) Synergistic bacterial compositions and methods of production and use thereof.
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
PH12016500207A1 (en) Anti-infective compounds
EP2730576A3 (en) Anti-infective compounds
MX349827B (en) Nitrogen containing compounds and their use.
PT2748165T (en) 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections.
WO2009140309A3 (en) Boron-containing small molecules
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
MX340533B (en) 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections.
MX2015002177A (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections.
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX349718B (en) Antimicrobial compounds and methods of making and using the same.
MY176900A (en) Antimicrobial compounds and methods of making and using the same
WO2011085990A8 (en) Anti - infective pyrido (1,2 -a) pyrimidines
MX2015016319A (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections.
PH12015502375A1 (en) Antimicrobial compounds and methods of making and using the same
MX342226B (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract.
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
PH12014501239A1 (en) Thymol and totarol antibacterial composition
WO2009053742A3 (en) Salts of nefopam and their use in therapy
SG178967A1 (en) Antimicrobial compositions and products
MX2013009456A (en) Vinyl -aryl - sulfones for use in peritoneal carcinomatosis.
MX337145B (en) Pharmaceutical compositions.